The Surfix team has its roots in the surface modification technologies based on organic chemistry. Surfix was founded as a spin-off from the department of Organic Chemistry of Wageningen University & Research.
Adriaan van der MeerR&D Engineer
Anke Schütz-TrillingTeamlead Assay Development
Carole van der Heijden-MesserliManagement Assistant
Elizabeth BarkaFinance Assistant
Erik SchreuderSenior Scientist
Franka ObenR&D Engineer
Geert BesselinkSenior Scientist
Hannah TettehQA/RA Officer
Hans DijkBusiness Development Manager
Henk DamSenior Scientist
Henk van MiddendorpSenior Project Manager
Janneke VeerbeekTeamlead Cartridge Development
Jhara van BuurenHR Manager
Joy LunsongaR&D Engineer
Kevin EversR&D Engineer
Marina DunaevaSenior Scientist
Michelle VerbruggenR&D Engineer
Mirac BozkirR&D Engineer
Rens SchonenbergR&D Engineer
Sabine RuttenR&D Engineer
Sieka BuisMarketing Assistant
Wout KnobenR&D/Project Manager
The Partners who invested in Surfix Diagnostics
Customized microsystems, vertically integrated solutions.
LioniX International is a leading global provider of customized microsystem solutions. We have driven technological and commercial development in our specialist fields—photonic integrated circuits and MEMS—since 2001.
Lionix International is a shareholder of Surfix Diagnostics since April 2020.
Saving lives and reducing cost through the development of accessible and easy-to-use diagnostic tests.
Together with a strong international network of world leading academic and corporate partners, Qurin is developing a revolutionary, low threshold nanotechnology-based platform for (early) diagnosis, monitoring and personalized treatment of cancer and other medical conditions using urine as a liquid biopsy.
Qurin Diagnostics is a shareholder of Surfix Diagnostics since April 2020.
PhotonDelta is a public-private partnership, located in Europe (Eindhoven, The Netherlands) consisting of a network of companies and high qualified knowledge institutes. PhotonDelta ecosystem growth objectives are driven by a highly experienced team in place, working from the outside in and strengthen the ecosystem from within. The team operates as an agent of accelerating for the development and reducing time-to-market of new applications.
Photon Delta invested in Surfix Diagnostics in April 2020 and is a shareholder since May 2021.
Oost NL (East Netherlands Development Agency) is an agency that focuses its activities and projects on strengthening and stimulating the economy of the provinces of Gelderland and Overijssel, the Netherlands. Oost NL supports starting and growth-phase SMEs.
Oost NL is a shareholder of Surfix Diagnostics since May 2021.